Sfoglia per AUTORE
LEE Y
Collezione AOU Città della Salute di Torino

  

Items : 3

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria. in American journal of hematology / Am J Hematol. 2024 Sep;99(9):1757-1767. doi: 10.1002/ajh.27413. Epub 2024 Jun 25.
2024
AOU Città della Salute di Torino

Kiialainen A; Gentile B; Buatois S; Panse J; Ueda Y; Lekue CB; Lee Y; Giai V; Hus M; Bonito D; Barcellini W; Yenerel MN; Nur E; Kim JS; Clé DV; Scheinberg P; Patel H; Sreckovic S; Uguen M; Edwards J; Nagy Z; Kulasekararaj AG;

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2.
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino

Barretina Ginesta MP; Uggeri S; Rulli E; Laudani ME; Lissoni AA; Petrella M; Tognon G; Ferrero A; Manso L; Takehara K; Tasca G; Zamagni C; McQueen J; Nakagawa S; Piovano E; Pardo B; Lee YC; Nishio S; Allan K; Fariñas-Madrid L; Parma G; Marth C; Marmé F; Rabaglio M; Antill Y; Choi CH; Hudson E; Galli F; Harano K; et alii...

Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. in International journal of cancer / Int J Cancer. 2017 May 1;140(9):1976-1984. doi: 10.1002/ijc.30618. Epub 2017 Feb 27.
2017
AOU Città della Salute di Torino

Fehringer G; Brenner DR; Zhang ZF; Lee YA; Matsuo K; Ito H; Lan Q; Vineis P; Johansson M; Overvad K; Riboli E; Trichopoulou A; Sacerdote C; Stucker I; Boffetta P; Brennan P; Christiani DC; Hong YC; Landi MT; Morgenstern H; Schwartz AG; Wenzlaff AS; Rennert G; McLaughlin JR; Harris CC; Olivo-Marston S; Orlow I; Park BJ; Zauderer M; et alii...